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doi:10.1Objectives:Annuloplasty for functional tricuspid regurgitation may sometimes be ineffective because of cham-
ber dilation and valve tethering. This study compared a novel technique, right ventricle (RV)–papillary muscle
approximation, with annuloplasty in experimentally-produced tricuspid regurgitation.
Methods: RVs of isolated porcine hearts (n ¼ 10) were statically pressurized, which led to RV dilation and
central tricuspid regurgitation. Regurgitant flow was measured with a saline solution–filled column. The head
of the anterior papillary muscle was approximated to 4 points on the ventricular septum. Next, a prosthetic
ring was implanted, and then RV–papillary muscle approximation was combined. Tricuspid annular dimension,
RV geometry, and tricuspid valve tethering were analyzed with 3-dimensional echocardiography.
Results: Tricuspid regurgitation (2270  186 mL/min) was reduced by RV–papillary muscle approximation
alone (214  45 mL/min; P<.05) more than by annuloplasty alone (724  166 mL/min; P<.05). Combined
RV–papillary muscle approximation and annuloplasty resulted in the least regurgitation (80  39 mL/min).
RV–papillary muscle approximation reduced tricuspid septolateral diameter (25%; P< .05), and annular
area (23%; P<.05), as did annuloplasty. RV–papillary muscle approximation also reduced RV sphericity index
(33%; P< .05) and tricuspid tethering height (54%; P< .05), whereas annuloplasty did not. Direction of
RV–papillary muscle approximation did not independently affect outcomes.
Conclusions: This ex vivo study suggests that RV–papillary muscle approximation potentially repairs tricuspid
regurgitation better than annuloplasty by improving ventricular sphericity and valve tethering as well as annular
dimension. (J Thorac Cardiovasc Surg 2012;144:235-42)Functional tricuspid regurgitation (TR) is commonly caused
by tricuspid annular dilation and right ventricular enlarge-
ment, which is often secondary to left-sided valve and
ventricular dysfunction or to pulmonary hypertension and
adversely affects cardiac-related mortality.1,2 Tricuspid
annuloplasty (TAP) for functional TR, concomitant with
repair of left-sided valve disease, generally results in good
outcome; still, no fewer than 10% of the patients have resid-
ual or recurrent moderate to severe TR on follow-up.3 Tri-
cuspid valve tethering, presumably as a result of outward
displacement of papillary muscles (PMs) in the dilated right
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Sas a factor that decreases the durability of TAP.4-6 This
observation is supported by the recent in vitro study
revealing that tricuspid annular dilation and PM
displacement independently cause TR.7 A treatment strat-
egy that addresses both PM displacement and annular dila-
tion is therefore likely to be more effective than TAP alone.
In functional mitral regurgitation, valve tethering from
PM displacement is also considered an important mecha-
nism.8,9 Recent reports describing novel intraventricular
techniques that relocate the displaced posterior PM to
its normal position10,11 or reposition both PMs to their
midline12-15 have shown successful treatment of
functional mitral regurgitation with reduction of mitral
valve tethering.10,12,14 Inspired by these observations, we
developed an analogous technique of right ventricle–PM
approximation (RV-PMA) to treat functional TR at the
level of the PMs. This involves approximating the head of
the anterior PM arising from the right ventricular free
wall to the ventricular septum. The objective of this
study was to examine the effects of the RV-PMA tech-
nique on TR, tricuspid annular dimension, right ventric-
ular geometry, and tricuspid valve tethering and to
compare them with TAP in an ex vivo TR model with
isolated porcine hearts analyzed with 3-dimensional
(3D) echocardiography.rdiovascular Surgery c Volume 144, Number 1 235
Abbreviations and Acronyms
3D ¼ 3-dimensional
A-M ¼ anterior papillary muscle to medial
papillary muscle [suture position]
A-P ¼ anterior papillary muscle to posterior
papillary muscle [suture position]
A-S1 ¼ anterior papillary muscle to the midpoint
between medial and posterior papillary
muscles [suture position]
A-S2 ¼ anterior papillary muscle to intersection
of septum and the perpendicular line on
the suture of anterior papillary muscle
[suture position]
PM ¼ papillary muscle
RV-
PMA
¼ right ventricle–papillary muscle
approximation
TAP ¼ tricuspid annuloplasty
TR ¼ tricuspid regurgitation





Ex Vivo Isolated Heart Model
Isolated fresh porcine hearts were obtained from a slaughterhouse.
Hearts were selected on the basis of the intact state of the right ventricles.
Approximately 30% of these hearts were selected for the experiments by
excluding the hearts with injuries of tricuspid valve, right ventricular
wall, or ventricular septum. The hearts were then tested by manual saline
solution injection. Hearts that had tricuspid valve leaflet prolapse or were
without apparent TR were also excluded. The hearts (n ¼ 10; 424  14 g)
that showed easily visible central TR were used for this ex vivo model.
The posterior wall of the left ventricle was resected, and the remainder
of the heart was mounted on a flow loop in a saline solution–filled tank
(37C). Pulmonary valve leaflets were removed, and the pulmonary artery
was connected to saline solution–filled tubing and column. The top of the
saline solution–filled columnwas open to the atmosphere. The height of the
saline solution–filled column was varied among 27, 55, and 82 cm above
the surface in the tank to pressurize the right ventricle to 20, 40, and 60
mm Hg, respectively. The closing volume of the tricuspid valve was ex-
cluded from the TR flow by starting measurements after the tricuspid valve
was completely closed under the pressure. Then the TR flow (in milliliters
per minute) was calculated bymeasuring the reduced volume in the column
from 5 to 60 seconds, depending on the amount of TR flow (Figure 1, A).
The actual changed heights of the saline solution–filled column were at
most 1.2, 2.0, and 2.9 cm, equivalent to 0.9, 1.5, and 2.1 mm Hg, below
the set height under 20, 40, and 60 mm Hg pressures, respectively.
Surgical Technique of RV-PMA
Sutures (2-0 Ethibond; Ethicon, Inc, Somerville, NJ) were placed with
a polytetrafluoroethylene pledget (7 mm in diameter) at the head of anterior
PM and pulled toward 4 points on the ventricular septum: medial PM
(A-M), posterior PM (A-P), the midpoint between medial and posterior
PMs (A-S1), and the intersection of the septum and the perpendicular
line on the suture of anterior PM (A-S2). The virtual plane in which the su-
tures were pulled and the plane of tricuspid annulus were kept parallel
(Figure 1, B and C). The distances between the anterior PM and the septum
were reduced by RV-PMA, the extent of which was either 0% (initial posi-
tion), 25%, 50%, 75%, or 100% (direct contact between the PM and the
septum; Figure 1, D). To evaluate annuloplasty, a moderately undersized236 The Journal of Thoracic and Cardiovascular Surgprosthetic rigid ring (distance between anteroseptal and posteroseptal com-
missures 29 mm, n¼ 9; 28 mm, n¼ 1), manufactured for research purpose,
was sutured onto the tricuspid annulus with 7 to 9 single sutures (3-0 Ethi-
bond; Ethicon) as TAP. The efficacy of this ring in reducing TR has been
established in acute and long-term animalmodels of TR induced by isolated
tricuspid annular dilatation.16 To evaluate the additive effects of RV-PMA
with annuloplasty, the distances between the anterior PM and the septum
were reduced again from 0% to 100% extent in the hearts after TAP.
Echocardiographic Measurement
The 3D echocardiographic data were acquired from the hearts under 40
mm Hg of right ventricular pressure by the full-volume acquisition mode
with a matrix array probe X7-2 (2–7 MHz) on an iE33 system (Philips
Healthcare, Andover, Mass). The 3D echocardiographic data were then an-
alyzed offline in the multiplanar 3D quantification mode of Philips Qlab
software17 (version 8.1) to measure the septolateral diameter, the antero-
posterior diameter, and the area of the tricuspid annulus (Figure 1, E);
the right ventricular sphericity index (RVSI); and the tricuspid valve teth-
ering height (Figure 1, F). For the tricuspid annular area, the most appro-
priate plane was defined to project some portions of tricuspid annulus as
an approximate 2-dimensional shape, because the Qlab acquisition soft-
ware does not accommodate the direct calculation of the 3D-shaped area
of the tricuspid valve. For the RVSI calculation with 3D echocardiographic
data, the tricuspid annular line, equivalent to the line for the septolateral di-
ameter, right ventricular long-axis line from the true right ventricular apex
to the midpoint of the tricuspid annular line, and the right ventricular short-
axis line between the right ventricular wall and the septum perpendicular to
the right ventricular long-axis line at its midpoint were determined. The
RVSI was calculated as a ratio of the right ventricular short-axis line to
the right ventricular long-axis line (Figure 1, F). For the tricuspid valve
tethering height, the largest height between the tricuspid annular line and
the coapting point between the tricuspid valve leaflets was determined
(Figure 1, F). In addition, acquired 3D data files were exported into the
4-D Echo View software (TomTec, Munich, Germany) to calculate the
right ventricular volume by the method of disc summation, as described
previously elsewhere.18
Statistical Analysis
Measurements are presented as mean  SEM. Statistical significance
was evaluated with STATA/IC software (version 10.1; StataCorp LP, Col-
lege Station, Tex) by repeated measures analysis of variance, followed by
comparisons between control and experimental conditions by the Dunnett
test or Fisher least significant difference comparison test among multiple
groups.RESULTS
Effects of RV-PMA and TAP on Tricuspid
Regurgitation Flow
The effects of RV-PMA on TR were compared with those
of TAP in our unique ex vivo porcine heart model. The TR
flow decreased proportionately to the extent of RV-PMA
(Figure 2, A). Ring TAP alone also reduced the TR flow;
however, TAP alone was less effective than 100%
RV-PMA alone (Figure 2, A). Even with TAP, RV-PMA fur-
ther reduced TR flow (Figure 2, A). No significant differ-
ences were observed among the 4 directions of RV-PMA
regardless of TAP (Figure 2, B). The TR flow changed ac-
cording to the right ventricular pressure; however, the ef-
fects of RV-PMA and TAP persisted under the different
right ventricular pressures (Figure 2, C).ery c July 2012
FIGURE 1. Experimental procedure and echocardiographic analysis. A, Experimental setups of saline solution–filled tank and column. Height of the saline
solution–filled column above the tank (a) was variable to pressurize the right ventricle (RV) from 20 to 60 mm Hg. The tricuspid regurgitation flow (in
milliliters per minute) was calculated by measuring the reduced height (b) in the column for 5 to 60 seconds after the right ventricle was pressurized
and tricuspid valve was closed. B, Schematic drawing of right ventricle–papillary muscle (PM) approximation. The anterior papillary muscle arises
from the right ventricular wall. Medial and posterior papillary muscles arise from the ventricular septum. The head of the anterior papillary muscle is ap-
proximated to the 4 points of the septum: the medial papillary muscle (A-M), the posterior papillary muscle (A-P), the midpoint between the medial papillary
muscle and the posterior papillary muscle (A-S1), and the intersection of the septum and the perpendicular line on the anterior papillary muscle (A-S2). C, A
representative photograph of the tricuspid valve and sutures on the anterior papillary muscle. D, The distance between the anterior papillary muscle and
septum is reduced by papillary muscle approximation (PMA) in each direction. E and F, Three-dimensional echocardiography was used to measure tricuspid
annular dimension (E) and right ventricular geometry (F). The right ventricular sphericity index was calculated as a ratio of the right ventricular short-axis
line (d) to the right ventricular long-axis line (c).




SEffects of RV-PMA and TAP on the Tricuspid
Annular Dimension
The tricuspid annulus was initially distended, and the re-
gurgitant orifice was clearly observed at the center of tricus-
pid valve leaflets in the 0% RV-PMA group, whereas the
annulus visibly decreased in size and the regurgitant orifice
was hardly seen after RV-PMA. The tricuspid annulus, how-
ever, became distorted in the A-M group. The location of
coapting portions of the 3 leaflets changed from anterior
in the A-M group to posterior in the A-P group (Figure 3,A).
In 3D echocardiographic analysis, the septolateral diameter
of the tricuspid annulus was reduced by RV-PMA alone
similar, to the change seen with TAP alone (Figure 3, B).
On the other hand, the anteroposterior diameter was not sig-
nificantly changed by either RV-PMA or TAP (Figure 3, C).
The tricuspid annular area was reduced by RV-PMA alone
to the same level as that achieved by TAP alone (Figure 3,The Journal of Thoracic and CaD). There were no significant differences among the
RV-PMA directions in all the parameters (Figure 3, E-G),
except that septolateral diameters were smaller in the
A-M and A-S1 groups than those in the A-S2 and A-P
groups for 50% RV-PMA (Figure 3, E).
Effects of RV-PMA and TAP on Right Ventricular
Geometry and Tricuspid Valve Tethering
In 3D echocardiographic analysis, both the base of the
anterior PM and the lateral portion of the tricuspid annulus
were pulled toward the septum by RV-PMA, whereas only
the annulus was reduced in size by TAP (Figure 4, A).
The RVSI was reduced by RV-PMA alone but was not sig-
nificantly reduced by TAP alone. Even with TAP, RV-PMA
further reduced RVSI (Figure 4, B). The effects of RV-PMA
on the right ventricular volumewere analyzed with only the
data after TAP, because the large TR flow (>2000 mL/min)rdiovascular Surgery c Volume 144, Number 1 237
FIGURE 2. Changes of tricuspid regurgitation (TR) flow by right ventricle
(RV)–papillary muscle approximation (PMA) and tricuspid annuloplasty
(TAP). A, Without () tricuspid annuloplasty, tricuspid regurgitation flow
under 40 mm Hg of right ventricular pressure was reduced by right ventri-
cle–papillary muscle approximation. Tricuspid regurgitation flow was also
reducedby tricuspid annuloplasty. Evenwith (þ) tricuspid annuloplasty, right
ventricle–papillarymuscle approximation further reduced tricuspid regurgi-
tation flow. Asterisk indicates P<.05 versus no annuloplasty with 0% pap-
illary muscle approximation by Dunnett t test. Dagger indicates P< .05
versus tricuspid annuloplasty with 0% papillary muscle approximation by
Dunnett t test. B, Tricuspid regurgitation flow was not different among the
directions of right ventricle–papillary muscle approximation (details of di-
rections given in Figure 1) according to analysis of variance.NS, Not signif-
icant. C, Tricuspid regurgitation flow under 20 or 60 mm Hg of right
ventricular pressurewas less ormore than that under 40mmHg, respectively,
but the effects of right ventricle–papillary muscle approximation and tricus-
pid annuloplasty were similar regardless of the right ventricular pressure.
Asterisk indicates P<.05 by least significant difference comparison test.
Evolving Technology/Basic Science Yamauchi et al




Scould cause underestimation of the right ventricular volume
(165  10 mL) in the initial condition of the hearts without
RV-PMA or TAP, as compared with the volumes after 50%
RV-PMA (172 12mL) and TAP alone (184 12mL). Af-
ter TAP, 100%RV-PMA significantly reduced right ventric-
ular volume (Figure 4, C). The tricuspid valve tethering
height was also reduced by RV-PMA alone but not by
TAP alone. Even with TAP, RV-PMA reduced tethering
height (Figure 4, D). Among the RV-PMA directions,
both RVSI and right ventricular volume were less in the
A-M group than in the A-P and A-S2 groups with 100%
RV-PMA, whereas a significant difference was shown
only in the RVSI with 50% RV-PMA (Figure 4, E and F).
There were no significant differences among the RV-PMA
directions in the analyses of tricuspid valve tethering height
(Figure 4, G).DISCUSSION
The results of this ex vivo study investigating the effects
of RV-PMA on TR demonstrated several findings. First, RV-
PMA reduced TR, independent of TAP. Second, RV-PMA
reduced the septolateral diameter and the area of tricuspid
annulus. Third, RV-PMA reduced the RVSI and the volume
of the right ventricle. Fourth, RV-PMA reduced the tricus-
pid valve tethering height. Finally, TAP reduced the annular
dimension but not RVSI or tricuspid valve tethering. These
results suggest that RV-PMA potentially reduces TR by ad-
dressing right ventricular and tricuspid valve geometry
simultaneously.
Although the concept of RV-PMA derives from the expe-
riences with relevant techniques in functional mitral regur-
gitation,10-15 the more complicated PM configuration in the
right ventricle makes RV-PM approximation more chal-
lenging than the analogous left ventricular operation. As op-
posed to the prominent dual PM configuration of the normal
left ventricle, the right ventricle has asymmetric alignment
of the PMs, comprising a large anterior PM on the right ven-
tricular free wall and relatively small medial and posterior
PMs on the septal side (Figure 1, B). The anterior PM is lo-
cated beneath the commissure of the anterior and posterior
leaflets, and it has a number of chordal insertions to both
leaflets. The medial and posterior PMs are located beneath
the anteroseptal and posteroseptal commissures, respec-
tively, and they have chordal insertions from the corre-
sponding leaflets. The septal leaflet also has multiple
chordal attachments directly to the right ventricular septal
wall.19 With functional TR, the tricuspid annulus dilates
by more than 40%, mainly at the anterior and posterior seg-
ments.7 The septolateral diameter of the annulus is in-
creased depending on the severity of functional TR.20 The
right ventricular wall concurrently dilates laterally, the
sphericity increases, and the anterior PM is displaced later-
ally, resulting in tricuspid valve tethering and incompleteery c July 2012
FIGURE 3. Changes in tricuspid annular dimension produced by right ventricle–papillary muscle approximation (PMA) and tricuspid annuloplasty (TAP).
A, These are representative photographs of tricuspid valve under 40 mm Hg pressure without () tricuspid annuloplasty before (0%) and after (100%) pap-
illary muscle approximation toward the 4 directions (details of directions given in Figure 1). Black dotted lines reflect the contour of the tricuspid annulus
before papillary muscle approximation. Black circles indicate coapting portions of 3 leaflets. AL, Anterior leaflet; SL, septal leaflet; PL, posterior leaflet. B
through G, According to the 3-dimensional echocardiographic analysis, the septolateral diameter (B) and the area (D) of the tricuspid annulus were reduced
by 50% and 100% papillary muscle approximation toward the septum (A-S1) as well as by performance of (þ) tricuspid annuloplasty, although the ante-
roposterior diameter of the tricuspid annulus (C) was not changed by either papillary muscle approximation or tricuspid annuloplasty (analysis of variance).
Among the directions of papillary muscle approximation, the tricuspid annular diameter (E and F) and area (G) did not differ, except for the septolateral
diameter with 50% papillary muscle approximation, which was less in the A-M and the A-S1 groups than in the A-S2 and the A-P groups (E). Asterisk
indicates P<.05 by least significant difference comparison test. NS, Not significant.




Svalve closure.4-6 To reverse these pathologic changes, we
considered approximation of the anterior PM to the
ventricular septum as a reasonable way to reduce theThe Journal of Thoracic and Caseptolateral dimension of the right ventricle. To determine
the optimal method of RV-PMA, we investigated the direc-
tions and the extent of approximation.rdiovascular Surgery c Volume 144, Number 1 239
FIGURE 4. Changes in right ventricular (RV) geometry (sphericity and volume) and tethering height by right ventricle–papillary muscle approximation
(PMA) and tricuspid annuloplasty (TAP). A, The representative cross-sectional 2-dimensional echocardiographic images of the hearts in the groups without
() annuloplasty (0%, 50%, and 100% papillary muscle approximation toward A-S1) and the group with (þ) annuloplasty (0% papillary muscle approx-
imation), reproduced by the multiplanar 3-dimensional quantification mode of the Qlab software (Philips Healthcare, Andover, Mass). Arrows indicate the
head of anterior papillary muscles. TV, Tricuspid valve. B, According to the 3-dimensional echocardiographic analysis, right ventricular sphericity index
(RVSI) was reduced by papillary muscle approximation toward the septum (A-S1, see Figure 1 for details of directions) regardless of annuloplasty. Right
ventricular sphericity index was not significantly reduced by annuloplasty except in the 100% papillary muscle approximation group. NS, Not significant.
Asterisk indicates P<.05 by least significant difference comparison test. C, Right ventricular volumewas reduced by 100% papillary muscle approximation
(A-S1). D, Tethering height of valve was reduced by papillary muscle approximation (A-S1) regardless of annuloplasty. Annuloplasty did not change teth-
ering height. E and F, The A-M group showed the lowest right ventricular sphericity index and right ventricular volume among the papillary muscle ap-
proximation directions. G, There was no difference in the valve tethering height among the papillary muscle approximation directions according to
analysis of variance.
Evolving Technology/Basic Science Yamauchi et al









SAmong the RV-PMA directions, A-S1 (RV-PMA toward
the midpoint between the medial PM and the posterior PM)
reduced TR the most, although no statistically significant
differences was found with the other directions (Figure 2,
B). A-M (RV-PMA toward the medial PM) reduced RVSI
the most (Figure 4, E), but it distorted the annulus
(Figure 3, A). In applying a more balanced force on the an-
terior PM in the anteroposterior direction, A-S1 or A-S2
(RV-PMA toward the midportion of the septum) may gener-
ate less stress on the PM than do the other directions. With
respect to the height on the septum with which PM is ap-
proximated, we paid attention to keeping the PM sutures
parallel to the tricuspid annulus to enhance tricuspid valve
leaflet coaptation at the same height. Our preliminary trial,
pulling the anterior PM obliquely toward the septal segment
of the annulus, resulted in worsening of TR as a result of an-
terior leaflet prolapse (data not shown).
With respect to the extent of RV-PMA, the concept of
this method started from the idea to restore all the valve
structures (annulus, chordae, and PMs) closer to their nor-
mal position. It is unknown however, to what extent
RV-PMA restores the PM to its ‘‘normal’’ position in this
model. Given that 50% RV-PMA and TAP restore the
PM and annulus, respectively, the group of 50%
RV-PMAwith TAP should demonstrate the ‘‘normal’’ con-
dition of the tricuspid valve. Interestingly, 100% RV-PMA
worked better than 50% RV-PMA to reduce TR in this
study (Figure 2). Moreover, 100% RV-PMA itself restored
the tricuspid annular dimension similarly to the result seen
with TAP (Figure 3, B-D) and also reduced right ventricu-
lar volume (Figure 4, C).
Our ex vivo experimental setup allowed us to pass the su-
tures attached to the anterior PM of the right ventricle
through the septum into the left ventricle (Figure 1, B). In
an in vivo animal model or in a clinical setting, however, se-
cure placement of the sutures to anchor the head of the
anterior PM with septal wall in the dilated right ventricle
is potentially challenging. We speculate that 2 or more
pledget-reinforced mattress sutures would likely be re-
quired to distribute the forces applied and that pledget rein-
forcement of the sutures would be beneficial for a friable
tissue.
Study Limitations
Porcine hearts were used in this study because the ana-
tomic structures of the human heart and porcine hearts are
similar with respect to the components of tricuspid valve
(annulus, chordae, and PMs) and right ventricle.19 Our
unique experimental model with a nonbeating flaccid por-
cine heart neither is physiologic nor mimics exactly func-
tional TR. It does imitate the state of the arrested right
ventricle after cardioplegia, however, and therefore does
represent some of what the surgeon finds during passive sa-
line solution testing. The intrinsically compliant tricuspidThe Journal of Thoracic and Caannulus and thin right ventricular wall enable intracardiac
filling at relatively low pressure to expand the annulus
and right ventricle while the valve closes, imitating the ‘‘di-
lated’’ tricuspid annulus and ‘‘spherical’’ right ventricle in
systole, similar to the human mechanism of functional
TR.4 The applied right ventricular pressures (20–60 mm
Hg) are considerably higher than typical physiologic pres-
sures, except in advanced disease states, which were mim-
icked by this model to distend the tricuspid annulus and
right ventricle. Although it was not possible to keep the
right ventricular pressure exactly constant while measuring
TR flow, especially with massive TR, the effect of variable
pressure was minimized. To confirm these proposed mech-
anisms, the results in this ex vivomodel need to be validated
in an in vivo model. In such experiments, one would need to
assess the following questions: whether the TR reduction
and the right ventricular geometric changes by RV-PMA af-
fect cardiac stroke volume, or result in tricuspid stenosis,
and whether the right ventricular remodeling effects of
RV-PMA lead to a more competent tricuspid valve in the
long term.CONCLUSIONS
In summary, this ex vivo study suggests that RV-PMA po-
tentially repairs TR better than TAP by improving not only
annular dimension but also RVSI and valve tethering. Fur-
ther investigations are necessary with in vivo animal studies
to evaluate dynamic tricuspid valve function, right ventric-
ular contractility, and durability of this technique.References
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